Header cover image

Polish Healthcare Undervalued based on future growth

Results

1

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Scope Fluidics

Market Cap: zł446.1m

A biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland.

SCP

zł140.80

7D

-0.7%

1Y

-24.0%